Loading...
UK Trademark — IPO
EXSCEL Exenatide Study of Cardiovascular Event Lowering
Application UK00909220575 · DO-NOT-DISPLAY
Quick Facts
| Application Number | UK00909220575 |
| Status | DO-NOT-DISPLAY |
| Owner | ASTRAZENECA PHARMACEUTICALS LP |
| Filed | 2010-07-02 |
| Registered | 2010-12-17 |
| Renewal Due | 2020-07-02 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Is this trademark active?
EXSCEL Exenatide Study of Cardiovascular Event Lowering has a current status of DO-NOT-DISPLAY.
Mark Details (as filed at the IPO)
Mark description / limitation
Colour Claimed : Yellow, blue, purple, black.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 42 — Scientific & IT Services
Medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment of type 2 diabetes and their impact on cardiovascular disease; medical and scientific research services; conducting clinical trials.
Device Elements (Vienna Classification)
This figurative mark is indexed under the following Vienna categories by the UK IPO:
- 02.09.01 — Human beings
Timeline
- Filed: 2010-07-02
- Registered: 2010-12-17
- Renewal due: 2020-07-02
About This Trademark
'EXSCEL Exenatide Study of Cardiovascular Event Lowering' is a do-not-display trademark on the UK IPO register, owned by ASTRAZENECA PHARMACEUTICALS LP. The application (UK00909220575) was filed on 2 July 2010 and registered on 17 December 2010. The registration is set to expire on 2 July 2020.
This mark is recorded under Class 42 (scientific, IT & design services), specifically covering: Colour Claimed : Yellow, blue, purple, black.
The trademark is represented by DENNEMEYER & CO LTD..
Frequently Asked Questions
Who owns UK trademark UK00909220575 ('EXSCEL Exenatide Study of Cardiovascular Event Lowering')?
UK trademark UK00909220575 for the mark 'EXSCEL Exenatide Study of Cardiovascular Event Lowering' in Class 42 is recorded on the UK IPO register as owned by ASTRAZENECA PHARMACEUTICALS LP. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00909220575 currently a registered trademark?
No — the UK IPO records the status of UK trademark UK00909220575 for the mark 'EXSCEL Exenatide Study of Cardiovascular Event Lowering' as do-not-display.
Which goods or services does UK trademark UK00909220575 cover?
UK trademark UK00909220575 for the mark 'EXSCEL Exenatide Study of Cardiovascular Event Lowering' is registered in Class 42 (scientific, IT & design services). The filed specification reads: Class 42: Medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment of type 2 diabetes and their impact on cardiovascular disease; medical and scientific research services; conducting clinical trials.
When was UK trademark UK00909220575 filed?
UK trademark UK00909220575 for the mark 'EXSCEL Exenatide Study of Cardiovascular Event Lowering' was filed at the UK IPO on 2 July 2010 and registered on 17 December 2010.
When does UK trademark UK00909220575 need to be renewed?
UK trademark UK00909220575 for the mark 'EXSCEL Exenatide Study of Cardiovascular Event Lowering' is currently recorded as valid until 2 July 2020, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00909220575?
DENNEMEYER & CO LTD. is listed as the attorney / representative of record for UK trademark UK00909220575 for the mark 'EXSCEL Exenatide Study of Cardiovascular Event Lowering' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "EXSCEL Exenatide Study of Cardiovascular Event Lowering" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING | 85053858 | 606 | 2010-06-03 |
| EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING | 85053863 | 602 | 2010-06-03 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.